Massari, Leo; Fini, Milena; Cadossi, Ruggero; Setti, Stefania; Traina, Gian Carlo
November 2006
Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p56
Academic Journal
Background: Osteonecrosis of the femoral head is the end point of a disease process that results in bone necrosis, joint edema, and cartilage damage. It leads to joint arthritis that necessitates total hip arthroplasty in many patients. Because of its positive effects on osteogenesis and its chondroprotective effect of articular cartilage, pulsed electromagnetic field stimulation has been proposed as a method to prevent or delay the progression of osteonecrosis. Methods: A retrospective analysis of the results of treatment with pulsed electromagnetic field stimulation of seventy-six hips in sixty-six patients with osteonecrosis of the femoral head was performed. Patients with Ficat stage I, II, or III osteonecrosis of the femoral head were treated with pulsed electromagnetic field stimulation for eight hours per day for an average of five months. Clinical and diagnostic imaging information was collected at the start of the treatment and at the time of follow-up. The primary end point analyzed was the avoidance of hip surgery, and the secondary end point was limiting the radiographic progression (according to Ficat stage) of osteonecrosis of the femoral head. Results: Fifteen hips required a total hip arthroplasty; twelve of these hips were in patients with Ficat stage-III disease. The need for total hip arthroplasty was significantly higher in patients with Ficat stage-III disease than in patients with Ficat stage-I (p < 0.0001) or II (p < 0.01) disease at the beginning of treatment. Pulsed electromagnetic fields preserved 94% of Ficat stage-I or II hips. Furthermore, radiographic progression (according to Ficat stage) occurred in twenty hips (26%). Pain, present in all patients at the start of the treatment, disappeared after sixty days of stimulation in thirty-five patients (53%) and was of moderate intensity in seventeen patients (26%). Conclusions: The results of this study confirm that pulsed electromagnetic field treatment may be indicated in the early stages of osteonecrosis of the femoral head (Ficat stages I and II). Pulsed electromagnetic field stimulation may be able to either preserve the hip or delay the time until surgery. The authors hypothesize that the short-term effect of pulsed electromagnetic field stimulation may be to protect the articular cartilage from the catabolic effect of inflammation and subchondral bone-marrow edema. The long-term effect of pulsed electromagnetic field stimulation may be to promote osteogenic activity at the necrotic area and prevent trabecular fracture and subchondral bone collapse. Level of Evidence: Therapeutic Level IV. See Instructions to Authors on jbjs.org for a complete description of levels of evidence.


Related Articles

  • POSTERIOR ROTATIONAL OSTEOTOMY FOR NONTRAUMATIC OSTEONECROSIS WITH EXTENSIVE COLLAPSED LESIONS IN YOUNG PATIENTS. Atsumi, Takashi; Kajiwara, Toshihisa; Hiranuma, Yasunari; Tamaoki, Satoshi; Asakura, Yasuhiro // Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p42 

    Background: In young patients with nontraumatic femoral head osteonecrosis with extensive and collapsed lesions, joint preservation is a goal if total joint arthroplasty is to be avoided. We evaluated the effectiveness of a posterior rotational osteotomy in this patient population. Methods: We...

  • SURVIVORSHIP ANALYSIS AND RADIOGRAPHIC OUTCOME FOLLOWING TANTALUM ROD INSERTION FOR OSTEONECROSIS OF THE FEMORAL HEAD. Veillette, Christian J. H.; Mehdian, Hossein; Schemitsch, Emil H.; McKee, Michael D. // Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p48 

    Background: For early stages of osteonecrosis, preservation of the femoral head is the primary objective; however, there has not been a consensus on how best to achieve this goal. Core decompression alone is associated with a lack of structural support with inconsistent outcomes, whereas...

  • BONE IMPACTION GRAFTING FOR CORTICOSTEROID-ASSOCIATED OSTEONECROSIS OF THE KNEE. Rijnen, Wim H. C.; Luttjeboer, Jaap S.; Schreurs, B. Willem; Gardeniers, Jean W. M. // Journal of Bone & Joint Surgery, American Volume;Nov2006 Supplement 3, Vol. 88-A, p62 

    Background: Osteonecrosis of the distal portion of the femur produces a segment of dead bone in the weight-bearing portion of the femoral condyle, frequently associated with subchondral fracture and collapse and eventually resulting in secondary osteoarthritis. Treatment of these late stages of...

  • Alendronic acid.  // Reactions Weekly;3/24/2012, Issue 1394, p5 

    The article describes the case of a 58-year-old woman who developed osteonecrosis of the jaw (ONJ) while under alendronic acid treatment regimen for osteoporosis.

  • The leading joint hypothesis for spatial reaching arm motions. Ambike, Satyajit; Schmiedeler, James // Experimental Brain Research;Feb2013, Vol. 224 Issue 4, p591 

    The leading joint hypothesis (LJH), developed for planar arm reaching, proposes that the interaction torques experienced by the proximal joint are low compared to the corresponding muscle torques. The human central nervous system could potentially ignore these interaction torques at the proximal...

  • Risedronic acid.  // Reactions Weekly;6/5/2010, Issue 1304, p31 

    The article describes the cases of two patients who suffered from osteonecrosis and/or osteomyelitis while taking risedronic acid for osteoporosis.

  • Zoledronic acid.  // Reactions Weekly;6/5/2010, Issue 1304, p34 

    The article describes the case of a 61-year-old female patient who suffered from osteonecrosis of the jaw following monthly infusions of zoledronic acid for metastatic breast cancer.

  • Bevacizumab/corticosteroids.  // Reactions Weekly;3/16/2013, Issue 1444, p11 

    The article presents a case study of a patient who developed osteonecrosis while receiving bevacizumab and another patient who received corticosteroids.

  • Alendronic acid/denosumab.  // Reactions Weekly;May2014, Vol. 1502 Issue 1, p5 

    An abstract of the article "Jaw osteonecrosis in a patient with postmenopausal osteoporosis on antiresorptive treatment," by I. Kostoglou-Athanassiou and colleagues is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics